Related Articles
Evaluation of the soluble fragments of cytokeratin 19 (CK19) in non-small cell lung cancer (NSCLC)
Comparison of Cyfra 21-1, TPA and SCC tumor markers in esophageal squamous cell carcinoma.
Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib
Comparison of the serum fibrin‑fibrinogen degradation products with cytokeratin 19 fragment as biomarkers in patients with lung cancer
Serum levels of five tumor markers for lung cancer in patients with chronic renal failure.